10-Q quarterly report · filed Oct 23, 2026

Quest Diagnostics (DGX) Q3 2026 10-Q Quarterly Report

Short answer

Quest Diagnostics (DGX) filed its Q3 2026 10-Q quarterly report on Oct 23, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $3.1B (up 10.0% year over year) with net income of $312M.

Q3 2026 key financials · XBRL

Revenue
$3.1B
+10.0% YoY · +1.8% QoQ
Net income
$312M
+27.3% YoY · −2.5% QoQ
Operating margin
15.5%
EPS (diluted)
$2.78
+28.7% YoY · −2.1% QoQ

Source: XBRL data from the Quest Diagnostics (DGX) Q3 2026 10-Q on SEC EDGAR. USD.

Quest Diagnostics Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $3,097M, up 10.0% YoY from $2,816M, driven by DIS revenue growth of 10.2%
  • Operating margin 15.5% vs 13.7% YoY, net income $312M vs $245M
  • Best performer DIS: $3,035M revenue, up 10.2%; DS revenue $62M vs $61M
  • Operating cash flow $611M vs $563M; capital expenditures $166M vs $144M
  • Cash $797M vs $420M at December 31, 2025; reimbursement pressures and higher compensation costs remained headwinds

Risk Factors

  • No material changes to risk factors reported from December 31, 2025 Form 10-K
  • Carried-forward risks remain governed by the 2025 Annual Report’s risk-factor disclosures

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Quest Diagnostics quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.